Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera

Biochimie

Volumn 88, Issue 6, 2006, Pages 701-710

  Machiah, Deepa K ^a   Gowda, T Veerabasappa ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF MYSORE   (India)

Author keywords

Naja naja; Neurotoxin; Phospholipase A2; Venom; Withania somnifera

Indexed keywords

PHOSPHOLIPASE A2; SNAKE VENOM; WITHANIA SOMNIFERA EXTRACT; COBROTOXIN; GLYCOPROTEIN; PHOSPHOLIPASE A;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BODY WEIGHT; CATALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE; MOLECULAR DYNAMICS; NEUROTOXICITY; NONHUMAN; PURIFICATION; WITHANIA SOMNIFERA; AGAR GEL ELECTROPHORESIS; ANIMAL; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; FROGS AND TOADS; IN VITRO STUDY; ISOLATION AND PURIFICATION; MALE; MOUSE; PHYTOTHERAPY; PLANT ROOT; SKELETAL MUSCLE; SNAKE; SPECTROFLUOROMETRY; WITHANIA;

ANURA; NAJA NAJA; WITHANIA SOMNIFERA;

ANIMALS; ANURA; CELL SURVIVAL; COBRA; COBRA NEUROTOXINS; COBRA VENOMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, AGAR GEL; FEMALE; GLYCOPROTEINS; MALE; MICE; MUSCLE, SKELETAL; PHOSPHOLIPASES A; PHYTOTHERAPY; PLANT ROOTS; SPECTROMETRY, FLUORESCENCE; WITHANIA;

EID: 33745958163     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2005.12.006     Document Type: Article

References (68)

1. 2. In: Howthorne J.N., and Ansel G.B. (Eds). Phospholipids (1982), Elsevier Biomed. Press, New York 359
2. Waite M. The Phospholipases (1987), Plenum, New York (Hand book of lipid Research Ser.Vol.5)
3. 2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260 (1985) 11627
4. 2. Biochem. Pharmacol. 37 (1988) 3639
5. 2. J. Biol. Chem. 269 (1994) 13057
6. Mukharjee A.B., Mide L., and Pattabiraman N. Biochem. Pharmacol. 48 (1994) 1
7. Braganca B.M., and Sambray Y.M. Multiple forms of cobra venom phospholipase A. Nature 216 (1967) 1210
8. Shiloah J., Klibansky C., and De Vries A. Phospholipase isoenzymes from Naja naja venom I. Purification and partial characterization. Toxicon 11 (1973) 481
9. Jayanthi G.P., and Gowda T.V. Purification of acidic phospholipases from Indian cobra (Naja naja naja) venom. J. Chromat. 281 (1983) 393
10. 2: its effect on enzymatic and pathological activities. Toxicon 25 (1987) 929
11. 2 from Vipera russelii (Russell's viper) snake venom. Toxicon 26 (1988) 713
12. 2 from Indian cobra, (Naja naja naja) venom. Toxicon 27 (1989) 861
13. Takasaki C., Suzuki J., and Tamiya N. Purification and properties of several phospholipases A2 from the venom of Australian king brown snake (Pseudechis australis). Toxicon 28 (1990) 319
14. Ohkura N., Inoue S., Ikeda K., and Hayashi K. Isolation and characterization of a phospholipase A2 inhibitor from the blood plasma of the Thailand cobra, Naja naja kaouthia. Biochem. Biophys. Res. Commun. 200 (1994) 784
15. 2 Enzymes: Structure, Function and Mechanism (1997), John Wiley and Sons, New York 1
16. Ownby C.L., and Gutierrez J.M. Citrate inhibition of snake venom proteases. Toxicon 36 (1998) 1801
17. 2 from Indian cobra (Naja naja naja) venom. Toxicon 36 (1998) 921
18. 2) from Indian cobra (Naja naja naja) venom. Biochem. Int. 25 (1991) 1023
19. 2 from Indian cobra (Naja naja naja) venom. Toxicon 29 (1991) 1345
20. 2 from Indian cobra, (Naja naja naja) venom. Toxiocon 30 (1992) 1227
21. 2 inhibitors. J. Nat. Prod. 59 (1996) 977
22. 2 inhibitors ergophilones A and B. Tetrahedron 51 (1995) 6717
23. Lombordo D., and Dennis E.A. Cobra venom phospholipase A2 inhibition by manoalide: a novel type of phospholipase inhibitor. J. Biol. Chem. 260 (1985) 7234
24. Melo P.A., Nascimento M.C., Mors W.B., and Suarez-Kurtz G. Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata extracts and constituents. Eur. J. Pharmacol. 183 (1994) 572
25. Melo P.A., Nascimento M.C., Mors W.B., and Suarez-Kurtz G. Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata extracts and constituents. Eur. J. Pharmacol. 183 (1994) 572
26. 2 enzymes: structure, function and mechanism (1997), John Wiley and Sons Ltd, New York
27. 2 by synthetic peptides derived from the primary sequence. J. Biol. Chem. 271 (1996) 23992
28. Catanese J.J., and Kress L.F. Opossum serum α1-proteinase inhibitor: purification, linear sequence, and resistance to inactivation by rattle snake venom metalloproteinases. Biochemistry 32 (1993) 509
29. 2 enzymes. Biochim. Biophys. Acta 1533 (2001) 29
30. Deepa M., and Veerabasappa Gowda T. Purification and characterization of a glycoprotein inhibitor of toxic phospholipase from Withania somnifera. Arch. Biochem. Biophys. 408 (2002) 42-50
31. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265
32. Laemmli V.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680
33. 50 determination of snake venom using eight to ten experimental animals. Toxicon 24 (1986) 395
34. Harvey A.L., Marshall R.J., and Karlsson E. Effects of purified cardiotoxins from the Thailand cobra (Naja naja siamensis) on isolated skeletal and cardiac muscle preparations. Toxicon 20 (1982) 379
35. 2 isolated from Bothrops asper and Bothrops godmani snake venoms: effects on enzymatic and pharmacological properties. Toxicon 35 (1997) 241
36. 2 from Indian cobra (Naja naja naja) venom. Toxicon 36 (1998) 921
37. Shashidharamurthy R., Jagadeesha D.K., Girish K.S., and Kemparaju K. Variation in biochemical and pharmacological properties of Indian cobra (Naja naja) venom due to geographical distribution. Mol. Cell. Biochem. 229-I (2002) 93
38. Satish S., Tejaswini J., Krishnakantha T.P., and Gowda T.V. Purification of a class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja naja) venom. Biochimie 86 (2004) 203-210
39. Kini R.M., and Gowda T.V. Modification of venom purification of the Indian cobra (Naja naja naja). Curr. Sci. India 52 (1983) 70
40. Eterovic V.A., Hebert M.S., Hanley M.R., and Bennett E.L. The Lethality and spectroscopic properties of toxins from Bungarus multicinctus, venom. Toxicon 13 (1975) 197537
41. Hendon R.A., and Fraenkel-Conrat H. The role of complex formation in the neurotoxicity of crotoxin components A and B. Toxicon 14 (1976) 283
42. 2. J. Toxicol. Toxin Rev. 1 (1982) 205
43. 2 neurotoxin from the south American rattlesnake Crotalus durissus terrificus: purification of several isoforms and comparison of their molecular structure and of their biological activities. Biochemistry 27 (1988) 730-738
44. Chang C.C. Neurotoxins with phospholipase A2 activity in snake venoms. Proc. Natn. Sci. Counc. B.R.O.C 9 (1985) 126
45. Bon C., and Saliou B. Cerulotoxin: Identification in the venom of Bungarus fasciatus, molecular properties and importance of phospholipase A2 activity of neurotoxicity. Toxicon 21 (1983) 681
46. 2 inhibitors from Australian elapid sera. Biochem. J. 346 (2000) 139
47. 2. Biochimie 82 (2000) 833
48. 2 inhibitor from the blood plasma of Trimeresurus flavoviridis. J. Biochem. (Tokyo) 106 (1989) 966-971 (Dec)
49. 2 inhibitor from the blood plasma of Trimeresurus flavoviridis. J. Biol. Chem. 266 (1991) 1001
50. Ohkura N., Inoue S., Ikeda K., and Hayashi K. Isolation and characterization of a phospholipase A2 inhibitor from the blood plasma of the Thailand cobra, Naja naja kaouthia. Biochem. Biophys. Res. Commun. 200 (1994) 784
51. 2 myotoxins from its own venom: isolation, molecular cloning and biological properties. Biochem. J. 346 (2000) 631
52. Vidal J.C., and Stoppani A.O.M. Isolation and properties of an inhibitor of phospholipase A from Bothrops neuweidii venom. Arch. Biochem. Biophys. 147 (1971) 66
53. Cate R.L., and Bieber A.L. Purification and characterization of Mojave (Crotalus scutualtus scutulatus) toxin and its subunits. Arch. Biochem. Biophys. 189 (1978) 397
54. Ovadia M., Kochva E., and Moav B. The neutralization mechanism of Vipera palaestinae neurotoxin by a purified factor from homologous serum. Biochim. Biophys. Acta 491 (1977) 370
55. Domont G.B., Perales J., and Moussatche H. Natural antisnake venom proteins. Toxicon 29 (1991) 1183
56. 2 myotoxin inhibitor from the Plasma of the snake of Bothrops asper. Biochem. J. 326 (1997) 853
57. 2 myotoxins. Toxicon 37 (1999) 199
58. Jacobs R.S., Culver P., Langdon R., O'Brien T., and White S. Some pharmacological observations on marine natural products. Tetrahedron Lett. 41 6 (1985) 981-984
59. 2 inhibition by manoalide: a novel type of phospholipase inhibitor. J. Biol. Chem. 260 (1985) 7234
60. Wheeler L.A., Suchs G., Vries G.D., Goodrum D., Woldemussie E., and Muallem S. Manoalide, a natural sesquiterpenoid that inhibits calcium channels. J. Biol. Chem. 262 (1987) 6531
61. B.S. Vishwanath, Interaction of plant isolates with snake venom phospholipases. Ph.D. thesis, University of Mysore, India. (1986).
62. 2 Biochem. Pharmacol. 37 (1988) 3639
63. Davidson F.F., and Dennis E.A. Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J. Mol. Evol. 31 (1990) 228-238
64. 2 in Triton X-100 mixed micelles. Bioorg. Med. Chem. Lett. 2 (1992) 1343
65. Cherdchu C., and Karlsson E. Proteolytic-independent cobra neurotoxin inhibiting activity of Curcuma sp. (Zingiberaceae). Southeast Asian J. Trop. Med. Pub. Health 14 (1983) 176
66. Harris J.B., and Johnson M.A. Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of Australian tiger snake, Notechis scutatus scutatus. Clin. Exp. Pharmacol. Physiol. 5 (1978) 587
67. 2 by "Lipocortins" and Calpactins. An effect of binding to substrate phospholipids. J. Biol. Chem. 262 (1987) 1698
68. 2. Toxicon 27 (1989) 613